The coagulation profile of children admitted with dengue fever and correlation with clinical severity

Vijayakumar Balakrishnan, Simna L. L, Lalitha Kailas


Background: Dengue is one of the 17 Neglected Tropical diseases (NTD) addressed in the NTD road map. Objective of present study was to find out the correlation between coagulation profile abnormalities and clinical severity of dengue fever.

Methods: All cases of dengue fever in children below 12 years of age admitted to a tertiary care medical college of South India for a period of 18 months (January 2013- June 2014) were included in the study. The liver function tests, prothrombin time, International normalises ratio and activated partial thromboplastin level were estimated and correlated with severity.

Results: Of the 306 cases of children admitted with dengue fever, 131 (42.8%) were dengue fever without warning signs, 119 (38.8%) were dengue fever with warning signs and 56 (18.4%) were severe dengue according to WHO guidelines 2012. 20.9% cases had significant PT prolongation, 50.3% had INR >1.1 and 33.3% had aPTT prolongation. Of the 56 cases of severe dengue, 83.9% had PT prolongation, 96.4% had INR >1.1 and 91.1% had significant aPTT prolongation. The mean values of PT, INR and aPTT in severe dengue was 19±3.7sec, 1.5±0.3 and 46±7 sec respectively. These were well above the cut off values and showed statistically significant association with severe dengue (p<0.001) compared to non-severe dengue. Similarly, ALT elevation among the total cases also showed majority (67.3%) in the range of 40-400. Of the 56 cases of severe dengue, 30% had values above 1000 IU/l, 51% had AST levels 40-400, and 16% had 400-1000 and 2.5% below 40. Statistical analysis showed significant difference in AST and ALT elevation among dengue fever without warning signs, dengue fever with warning signs and severe dengue (p<0.001).

Conclusions: There is statistically significant association between prolongation of coagulation markers and severity of dengue. 


Activated partial thromboplastin time, Dengue fever, International normalised ratio, Prothromine time

Full Text:



World Health Organization. Global Strategy for Dengue Prevention and Control: WHO 2012-2020

Limkittikul K, Brett J, L'Azou M. Epidemiological trends of dengue disease in Thailand (2000-2011): a systematic literature review. PLoSNegl Trop Dis. 2014 Nov 6;8(11):e3241.

Isarangkura PB, Pongpanich B, Pintadit P, Phanichyakarn P, ValyaseviA.Hemostatic derangement in dengue haemorrhagic fever. Southeast Asian J Trop MedPublic Health. 1987 Sep;18(3):331-

Van Gorp EC, Setiati TE, Mairuhu AT, Suharti C, Cate Ht, Dolmans WM,et al. Impaired fibrinolysis in the pathogenesis ofdengue hemorrhagic fever. J Med Virol. 2002 Aug; 67(4):549-54.

Roy A, Sarkar D, Chakraborty S,Chaudhuri J, Ghosh P. Profile of hepatic involvement by dengue virus in dengue infected children. N Am J Med Sci. 2013 Aug;5(8):480-5.

Lin SW, Chuang YC, Lin YS, Lei HY, Liu HS, Yeh TM. Dengue

virus nonstructural protein NS1 binds to prothrombin/thrombin

and inhibits prothrombin activation. J Infect.2012; 64:325-34

Cabello-Gutiérrez C, Manjarrez-Zavala ME, Huerta-Zepeda A, Cime-Castillo J, Monroy-Martínez V, Correa BB, Ruiz-Ordaz BH. Modification of the cytoprotective protein C pathway during Dengue virus infection of human endothelial vascular cells. Thromb Haemost. 2009 May;101(5):916-28

Sosothikul D, Seksarn P, Pongsewalak S, Thisyakorn U, Lusher J. Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection. Thromb Haemost. 2007 Apr;97(4):627-34

Orsi FA, Angerami RN, Mazetto BM, Quaino SK, Santiago-Bassora F, Castro V,et al. Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: a case-control study comparing dengue fever patients with and without bleeding manifestations. BMC Infect Dis. 2013 Jul 28;13:350.

Huerta-Zepeda A, Cabello-Gutiérrez C, Cime-Castillo J, Monroy-MartínezV,Manjarrez-Zavala ME, Gutiérrez-Rodríguez M,et al. Crosstalk between coagulation and inflammation during Dengue virus infection. ThrombHaemost. 2008 May;99(5):936-43.

Chen LC, Shyu HW, Lin HM, Lei HY, Lin YS, Liu HS,et al. Dengue virus induces thrombomodulin expression in human endothelial cells and monocytes in vitro. J Infect. 2009 May;58(5):368-74.

Yeh TM, Liu SH, Lin KC, Kuo C, Kuo SY, Huang TY, et al. Dengue virus enhances thrombomodulin and ICAM-1 expression through the macrophage migration inhibitory factor induction of the MAPK and PI3K signaling pathways. PLoS One. 2013;8(1):e55018.

Wills B, Tran VN, Nguyen TH, Truong TT, Tran TN, Nguyen MD,et al. Hemostatic changes in Vietnamese children with mild dengue correlate with the severity of vascular leakage rather than bleeding. Am J Trop Med Hyg. 2009 Oct;81(4):638-44.

Khalil MA, Tan J, Khalil MA, Awan S, Rangasami M. Predictors of hospital stay and mortality in dengue virus infection-experience from Aga Khan University Hospital Pakistan. BMC Res Notes. 2014 Jul 27;7:473

Bashir A. Bashir, Osman K. Saeed, Babiker A. Mohammed, and Ali K. Ageep,“Partial Thromboplastin Time and Prothrombin Time as Predictors for Impaired Coagulation among PatientswithDengue Virus Infection in Red Sea State of Sudan.” International Journal of HematologicalDisorders,.vol.2,no.1(2015): 24-28.